Calidi Biotherapeutics (CLDI) Short term Debt (2022 - 2024)

Calidi Biotherapeutics has reported Short term Debt for 3 years, with the latest figure at $223000.0 in Q4 2024.

• On a quarterly basis, Short term Debt changed N/A year-over-year to $223000.0 in Q4 2024; TTM through Dec 2024 was $223000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $223000.0, changed N/A from the prior year.
• Short term Debt was $223000.0 for Q4 2024 at Calidi Biotherapeutics, up from $217000.0 in the prior quarter.
• The five-year high for Short term Debt was $1.0 million in Q4 2022, with the low at $205000.0 in Q1 2024.
• Average Short term Debt over 3 years is $476000.0, with a median of $220000.0 recorded in 2024.
• The largest YoY upside for Short term Debt was 78.3% in 2024 against a maximum downside of 78.3% in 2024.
• Over 3 years, Short term Debt stood at $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then sank by 77.7% to $223000.0 in 2024.
• The last three Short term Debt figures came in at $223000.0 (Q4 2024), $217000.0 (Q3 2024), and $211000.0 (Q2 2024), per Business Quant data.